Our Events

  • IBN interviews CEO of AryoGen Pharmed, Dr. Amir Farshchi

  • IBN interviews with Dr. Farshchi regarding Tocilizumab, which is recently approved by the Chinese Health Commission for it’s successful usage in patients with acute phase of COVID-19